These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1062 related items for PubMed ID: 15853989
21. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan. Chen DS. Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606 [Abstract] [Full Text] [Related]
22. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381 [Abstract] [Full Text] [Related]
23. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients. Dohmen K, Shigematsu H, Irie K, Ishibashi H. Hepatogastroenterology; 2003 Jul; 50(54):2022-7. PubMed ID: 14696457 [Abstract] [Full Text] [Related]
25. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma. Nakagawa N, Ikoma J, Ishihara T, Yasui N, Fujita N, Iwasa M, Kaito M, Watanabe S, Adachi Y. Cancer; 1999 Oct 15; 86(8):1437-40. PubMed ID: 10526270 [Abstract] [Full Text] [Related]
26. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma. Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J. J Gastroenterol Hepatol; 2008 Mar 15; 23(3):459-66. PubMed ID: 17854425 [Abstract] [Full Text] [Related]
27. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan. Tsai MC, Kee KM, Chen YD, Lin LC, Tsai LS, Chen HH, Lu SN. J Gastroenterol Hepatol; 2007 Jan 15; 22(1):92-8. PubMed ID: 17201888 [Abstract] [Full Text] [Related]
28. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A. Trop Gastroenterol; 2007 Jan 15; 28(1):19-23. PubMed ID: 17896605 [Abstract] [Full Text] [Related]
29. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Transfusion; 2007 Jan 15; 47(1):74-9. PubMed ID: 17207233 [Abstract] [Full Text] [Related]
30. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population. Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J. Liver Transpl; 2001 Jan 15; 7(1):51-8. PubMed ID: 11150423 [Abstract] [Full Text] [Related]
31. Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma. Ohba K, Kubo S, Tamori A, Hirohashi K, Tanaka H, Shuto T, Nishiguchi S, Kinoshita H. Surg Today; 2004 Jan 15; 34(10):842-8. PubMed ID: 15449154 [Abstract] [Full Text] [Related]
32. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. Fang Y, Shang QL, Liu JY, Li D, Xu WZ, Teng X, Zhao HW, Fu LJ, Zhang FM, Gu HX. J Infect; 2009 May 15; 58(5):383-8. PubMed ID: 19329189 [Abstract] [Full Text] [Related]
33. Impact of hepatitis B and C virus infection on the clinical prognosis of alcoholic liver cirrhosis. Yamanaka T, Shiraki K, Nakazaawa S, Okano H, Ito T, Deguchi M, Takase K, Nakano T. Anticancer Res; 2001 May 15; 21(4B):2937-40. PubMed ID: 11712790 [Abstract] [Full Text] [Related]
34. [Low prevalence of ant-hepatitis c virus antibodies in hepatocellular carcinoma in Senegal]. Ka MM, Herve P, Leguenno B, Ndiaye MF, Diop TM, Diop B, Dangou JM, Bao O, Brechot C. Ann Gastroenterol Hepatol (Paris); 1996 May 15; 31(6):329-32. PubMed ID: 8920074 [Abstract] [Full Text] [Related]
35. [Hepatita B and C virus infections in patients with hepatocellular carcinoma]. Crespo J, Dueñas C, Sánchez-Antolín G, Fábrega E, Carte B, Pons-Romero F. Med Clin (Barc); 1996 Feb 24; 106(7):241-5. PubMed ID: 8667672 [Abstract] [Full Text] [Related]
36. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M. Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327 [Abstract] [Full Text] [Related]
37. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma]. Jiang MD. Zhonghua Yi Xue Za Zhi; 1993 Mar 01; 73(3):131-4, 189. PubMed ID: 7686810 [Abstract] [Full Text] [Related]
38. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study. Vaiphei K, Pal NS, Arora SK. Indian J Pathol Microbiol; 2006 Jul 01; 49(3):357-61. PubMed ID: 17001884 [Abstract] [Full Text] [Related]
39. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Nawata H, Ishibashi H, Maeda Y, Kiyokawa H. Cancer Res; 1991 Jun 01; 51(11):2842-7. PubMed ID: 1851661 [Abstract] [Full Text] [Related]
40. HBV and HCV infection in Japanese dental care workers. Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M. Int J Mol Med; 2008 Jun 01; 21(6):791-9. PubMed ID: 18506374 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]